2.4.0.80019 - Disclosure - Subsequent Eventstruefalsefalse1false falsefalseFrom2012-06-01to2013-05-31http://www.sec.gov/CIK0001365160duration2012-06-01T00:00:002013-05-31T00:00:001true 1DOMK_NotesToFinancialStatementsAbstractDOMK_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Notes to Financial Statements2false 2us-gaap_SubsequentEventsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00The Company has entered into a Memorandum of Understanding to purchase 20% of Zaktek Ltd., a UK based innovative electronic products company. Zakteks main product is the phonepad+, an Apple Inc. approved tablet device that incorporates PDAS including the Apple iPhone and Samsung Galaxy products to improve functionality including video and gaming abilities.   Effective June 15, 2012, the Company's Shareholders appointed Andrew Ritchie, as CEO of the Company. Mr. Ritchie has not been appointed to any committees of the Board, as the Board does not presently have any committees.   On June 20, 2012, the Company formed a new wholly owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system, Barefoot Science   On June 25, 2012, the Company appointed Patrick Johnson as Vice President of corporate development.   On June 26, 2012, the Company entered into an employment agreement with Patrick Johnson.   On June 26, 2012, the Company entered into an agreement with RBL Communications to manage a complete social media program for the Company's wholly owned subsidiary, MuscleFoot, Inc.   On July 16, 2012, the Company appointed Sean Pena to the advisory committee of its wholly owned subsidiary, MuscleFoot, Inc.   On July 19, 2012, the Company, through its wholly owned subsidiary MuscleFoot, Inc., entered into an endorsement contract with Nick Symmonds.   On July 25, 2012, the Company, through its wholly owned subsidiary MuscleFoot, Inc., entered into an endorsement contract with Will Claye   On March 21, 2013 a portion of debt owing to Ian Nuttall totaling $30,000 was converted to 1,500,000 shares of common stock.   On April 12, 2013 the Company completed the acquisition of 15% of Barefoot-Science with the conversion of 2,500,000 series B into 5,000,000 shares of common stock.   On April 12, 2013 a portion of debt owing to Ian Nuttall totaling $30,000 was converted to 1,500,000 shares of common stock.   On April 23, 2013 the Company concluded its settlement with the previous principle to DoMark, Thomas Kidd, and delivered to him 2,000,000 shares of common stock as a full and final settlement of all outstanding legal issues.   In June 2013 the Company entered into an agreement to purchase 29% of Imagic for stock and cash. Imagic is a UK company that has patented, or patent pending, smartphone products. Domark is actively involved with the management and marketing direction of the company.   Domark has increased its holding in Imagic to 34% in September 2013.   On August 1, 2013 the Company entered into an office lease in Toronto, Ontario for a five year period. The future lease commitments on this lease are as follows;   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 84%">F/Y ending 5-31-2014</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 13%; text-align: right">19,082</td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>F/Y ending 5-31-2015</td> <td> </td> <td>$</td> <td style="text-align: right">22,899</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>F/Y ending 5-31-2016</td> <td> </td> <td>$</td> <td style="text-align: right">25,143</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>F/Y ending 5-31-2017</td> <td> </td> <td>$</td> <td style="text-align: right">25,593</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>F/Y ending 5-31-2018</td> <td> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">25,593</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">118,310</td> <td nowrap="nowrap"> </td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.No definition available.false0Note 13 - Subsequent EventsfalseSubsequent EventsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://domarkintl.com/role/SubsequentEvents12